Black Rock Inc. Catalyst Pharmaceuticals, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CPRX
# of Institutions
327Shares Held
94.6MCall Options Held
19.1KPut Options Held
51.1K-
Vanguard Group Inc Valley Forge, PA8.04MShares$170 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.23MShares$132 Million2.3% of portfolio
-
State Street Corp Boston, MA5.69MShares$120 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$63.8 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.8MShares$59.2 Million0.13% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.17B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...